VolitionRx Limited Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
VolitionRx Limited (VNRX) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $110.63 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2019-11-12
- VolitionRx Limited right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-09-30 was $136.23K.
- VolitionRx Limited right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-06-30 was -$14.16K.
- VolitionRx Limited right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-03-31 was -$11.44K.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month |
|---|---|---|---|
| 2019-09-30 | $136.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $122.07K derived: sum of 2 quarters · filed 2019-11-12 | $110.63K 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$14.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$25.60K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | -$11.44K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |